Ortin Global (BOM:539287) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 08, 2026)


BOM:539287 Ortin Global Ltd BOM:539287
42 GF Score
Price ₹16.48
GF Value ₹2.54
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Ortin Global Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Ortin Global's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

BOM:539287 vs ZTS, UTHR: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ortin Global's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ortin Global Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ortin Global's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Ortin Global's Margin of Safety % (DCF FCF Based) falls into.


BOM:539287
42GF Score
Ortin Global Ltd BOM:539287
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ortin Global (BOM:539287) Overvalued in 2026?

Based on GuruFocus' analysis, Ortin Global stock appears to be overvalued. The current stock price of ₹16.48 is trading 548.8% above its estimated GF Value™ of ₹2.54. GuruFocus considers Ortin Global to be Significantly Overvalued.

Key valuation signals for BOM:539287:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ₹2.54 vs. price of ₹16.48 (548.8% above fair value)
  • GF Score™: 42/100 with 8 warning signs

No single metric tells the full story. See the BOM:539287 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ortin Global Business Description

Other Exchanges ORTINGLOBE:India
Address G Block, Plot No. C-66, 9th Floor, 915, One BKC, Bandra Kurla Complex, Bandra East, Mumbai, MH, IND, 400051
Ortin Global Ltd is an Indian company engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helminthics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its API intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zidovudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others. Additionally, the company is also involved in the real estate business.
42GF Score

Get the complete analysis for BOM:539287

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹16.48
Price
₹2.54
GF Value